Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods

Fig. 1

Diagnostic value of IL1RN in PTC. a Comparison of IL1RN mRNA expression between PTC and normal tissues in TCGA. b Diagnostic efficacy of IL1RN as shown by the ROC curve. c Kaplan–Meier curve for progression-free survival (PFS) in H-IL1RN group and L-IL1RN group. d-g mRNA expression of IL1RN in 4 GEO verification cohorts (GSE3467, GSE33630, GSE58545, GSE60542). (H-K) ROC curve showing the diagnostic performance of IL1RN expression in the verification cohorts. *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 here and in the following figures

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us